In India, the radiology market is expected to increase from Rs. 407 billion in 2024 to Rs. 868 billion by 2030 at a 13.5% CAGR. Invicta Diagnostics Limited has a diagnostic chain and will enter the Indian stock market.
Socradamus Capital is responsible for managing the IPO, and Bigshare Services will look after the allotment process. Please check the Invicta Diagnostics Limited Tech IPO allotment status.
Get the complete analysis of the IPO through Invicta Diagnostics Limited DRHP and RHP.
Note: 50% of shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
Get better Invicta Diagnostics Limited reviews through the details mentioned below:
Here are the details about the Invicta Diagnostics Limited IPO share price:
The following list highlights the significant risks and strengths.
Strengths
Strong Commitment to Patient Safety: The company maintains strict quality control systems to catch errors early and protect patient well-being.
Supply Network for Equipment: They work with trusted suppliers for diagnostic tools, reagents, and consumables. This dependable network helps them maintain smooth operations even when challenges arise.
Advanced Technology and Skilled Workforce: The company operates modern diagnostic machinery and employs trained specialists who understand complex testing requirements.
Operational Preparedness During Health Disruptions: They have systems in place to manage operations during health emergencies, supply chain issues, or sudden changes in patient volume.
Risks
Reliance on Brand Reputation for Customer Visits: The company depends heavily on walk-in customers, which makes its brand image critical. Any dip in test accuracy, service quality, turnaround time, or patient experience can directly affect trust.
Heavy Dependence on the Flagship Centre: Their main hub in Thane handles a large share of tests, including samples sent from other branches. Any disruption there can halt operations.
Risks Linked to Operational Hubs: Along with the flagship facility, the company relies on three hub centres for pathology, basic radiology, and selected advanced tests. If any of these hubs face shutdowns, it could delay services.
High Dependence on Radiology Services: A major portion of the company’s business comes from radiology. This concentration exposes them to risks.
As of November 26, 2025, the Invicta Diagnostics IPO GMP has not been updated. You can view the IPO's live GMP and the subscription status. Also, verify the Invicta Diagnostics Limited DRHP and RHP before you click on the Apply Now button.
1. How is the Invicta Diagnostics IPO review?
Invicta Diagnostics Limited has a diagnostic chain in Maharashtra. The total IPO size is ₹28.12 Crore, and the listing date is 8 December 2025. For the latest details, you can also look for the GMP updates.
2. What is the Invicta Diagnostics Limited IPO date?
The IPO opening is 1 December 2025, and the closing date is 3 December 2025. Live subscription details can be monitored through FinnPick.
3. What is the Invicta Diagnostics IPO price today?
The Invicta Diagnostics Limited IPO price is ₹80 to ₹85 as of November 26, 2025. Also, don't forget to verify the Invicta Diagnostics IPO DRHP and RHP.
4. Do I need a demat account to bid for the Invicta Diagnostics Limited IPO?
Yes, a demat account is required to bid for the Invicta Diagnostics Limited IPO. Click here to get the ultimate list of the top demat account providers.
